"Three years after the creation of France Biolead, which brings together all stakeholders in biomedicines across the country, CEO Laurent Lafferrère believes the sector has now become more unified. However, funding, public support, and European-level coordination are still lacking to accelerate progress in this strategic field of innovative, living-derived medicines that are at the forefront of treating serious diseases and rare conditions."